Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 3, 2000, Pages 697-704

  Ezzet, F ^a   Van Vugt, M ^b,c   Nosten, F ^b,d,e,f   Looareesuwan, S ^d,e   White, N J ^d,e,f  

^a NOVARTIS PHARMA AG   (Switzerland)

^b SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d MAHIDOL UNIVERSITY   (Thailand)

^e MAHIDOL UNIVERSITY   (Thailand)

^f JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER; BENFLUMETOL;

ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG HALF LIFE; FOOD INTAKE; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MINIMUM INHIBITORY CONCENTRATION; NEUROTOXICITY; PHARMACODYNAMICS; PRIORITY JOURNAL;

ADULT; ANIMALS; ANTIMALARIALS; AREA UNDER CURVE; ARTEMISININS; BIOLOGICAL AVAILABILITY; CHILD; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; ETHANOLAMINES; FLUORENES; FOOD-DRUG INTERACTIONS; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PROSPECTIVE STUDIES; SESQUITERPENES; TREATMENT OUTCOME;

EID: 0033998085     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.3.697-704.2000     Document Type: Article

References (20)

1. Brockman, A., R. E. L. Paul, T. J. C. Anderson, I. Hackford, L. Phaiphun, F. Nosten, and K. P. Day. 1999. Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand. Am. J. Trop. Med. Hyg. 60:14-21.
2. Davidian, M., and A. R. Giltinan. 1995. Nonlinear models for repeated measurements data. Chapman & Hall, Ltd., London, England.
3. Ezzet, F., R. Mull, and J. Karbwang. 1998. The population pharmacokinetics of CGP 56697 and its effects on the therapeutic response in malaria patients. Br. J. Clin. Pharmacol. 46:553-561.
4. Gibaldi, M., and D. Perrier. 1982. Pharmacokinetics, 2nd ed. Marcel Dekker, Inc., New York, N. Y.
5. Hussein, Z., J. Eaves, D. B. Hutchinson, and C. J. Canfield. 1997. Population pharmacokinetics of atovaquone in patients with acute malaria caused by Plasmodium falciparum. Clin. Pharmacol. Ther. 61:518-530.
6. Lindstrom, M. J., and D. M. Bates. 1990. Nonlinear mixed effects models for repeated measures data. Biometrics 46:673-687.
7. Milton, K. A., G. Edwards, S. A. Ward, M. L. Orme, and A. M. Breckenridge. 1989. Pharmacokinetics of halofantrine in man: effects of food and dose size. Br. J. Clin. Pharmacol. 28:71-77.
8. Molyneux, M. E., S. Looareesuwan, I. S. Menzies, S. L. Grainger, R. E. Philips, Y. Wattanagoon, R. P. H. Thompson, and D. A. Warrell. 1989. Reduced hepatic blood flow and intestinal malabsorption in severe falciparum malaria. Am. J. Trop. Med. Hyg. 40:470-476.
9. Nosten, F., F. O. ter Kuile, C. Luxemburger, C. Woodrow, D. E. Kyle, T. Chongsuphajaisiddhi, and N. J. White. 1993. Cardiac effects of antimalarial treatment with halofantrine. Lancet 341:1054-1056.
10. Price, R. N., F. Nosten, C. Luxemburger, A. Kahm, A. Brockman, T. Chongsuphajaisiddhi, and N. J. White. 1995. Artesunate versus artemether in combination with mefloquine for the treatment of multidrug resistant falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 89:523-527.
11. ter Kuile, F. O., G. Dolan, F. Nosten, M. D. Edstein, C. Luxemburger, L. Phaipun, T. Chongsuphajaisiddhi, H. K. Webster, and N. J. White. 1993. Halofantrine versus mefloquine in the treatment of multi-drug resistant falciparum malaria. Lancet 341:1044-1049.
12. van Vugt, M., A. Brockman, B. Gemperli, C. Luxemburger, I. Gathmann, C. Royce, T. Slight, S. Looareesuwan, N. J. White, and F. Nosten. 1998. A randomised comparison of artemether-benflumetol and artesunate-mefloquine in the treatment of multidrug-resistant falciparum malaria. Antimicrob. Agents Chemother. 42:135-139.
13. van Vugt, M., F. Ezzet, L. Phaipun, F. Nosten, and N. J. White. 1998. The relationship between capillary and venous concentrations of benflumetol. Trans. R. Soc. Trop. Med. Hyg. 92:564-565.
14. van Vugt, M., P. Wilairatana, B. Gemperli, I. Gathmann, L. Phaipun, A. Brockman, C. Luxemburger, N. J. White, F. Nosten, and S. Looareesuwan. 1999. Efficacy of six doses of artemether-benflumetol in the treatment of multi-drug resistant falciparum malaria. Am. J. Trop. Med. Hyg. 60:936-942.
15. 14a. van Vugt, M., F. Ezzet, F. Nosten, and N. J. White. 1999. No cardiotoxicity with high dose lumefantrine. Am. J. Trop. Med. Hyg., in press.
16. von Seidlein, L., S. Jaffar, and B. Greenwood. 1997. Prolongation of the QTc interval in African children treated for falciparum malaria. Am. J. Trop. Med. Hyg. 56:4494-4497.
17. White, N. J. 1994. Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives. Trans. R. Soc. Trop. Med. Hyg. 88:41-43.
18. White, N. J. 1997. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob. Agents Chemother. 41:1413-1422.
19. White, N. J. 1998. Preventing antimalarial drug resistance through combinations. Drug Resistance Updates 1:3-6.
20. Zeng, M. Y., Z. L. Lu, S.-C. Yang, M. Zhang, J. Liao, S.-L. Liu, and X. H. Teng. 1996. Determination of benflumetol in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. 681:299-306.